Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study. - Wikidata - wikimedia - TriplyDB

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study.

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study.

http://www.wikidata.org/entity/Q37580446

about

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives Perspectives of HER2-targeting in gastric and esophageal cancer.The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2.Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.Correlation of Trastuzumab-based Treatment with Clinical Characteristics and Prognosis in HER2-Positive Gastric and gastroesophageal Junction Cancer: A retrospective single center analysis.Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.Current therapeutic landscape for advanced gastroesophageal cancers.Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study.

P2860

Q28077666-A617DECC-9A01-4269-B339-01D5ACCDAED4 Q38848389-88233C97-93D7-439D-8DB4-4BAFD641F72D Q41488096-47CB7527-34EA-4549-98A4-A41D82C454E7 Q47100522-36FABE2E-DA41-4394-BA60-DBDB32321137 Q47190729-C9DA98E9-12C8-4E5D-9D12-AA8651D479D1 Q47678852-6E881840-D50A-48FF-A33C-268A14562222 Q52581752-CCF5C6F6-A1F0-4C15-ACB4-AB638C402710 Q54109361-AF4961ED-B9A2-4D78-94FF-273306A34420

P2860

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study.

http://www.wikidata.org/entity/Q37580446

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@en

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@nl

type

label

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@en

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@nl

prefLabel

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@en

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@nl

P1433

Q37580446-417ED4BD-5F37-439A-AA40-5F12521F6DAE

P1476

Q37580446-879CC035-2C2F-444A-BA14-0BE58C05FB0A

P2093

Q37580446-037A6D71-E3F8-4AFA-A8AE-E7DEAA52FE0B

Q37580446-1F45B676-4049-417E-8F0C-5A7251C57B09

Q37580446-33F0F2AD-1FAC-4CE2-B331-AAA2FD6E101E

Q37580446-3F7D1960-1853-4211-8C5D-F64424F0C5CD

Q37580446-4095426A-F81A-4C42-AA15-1D20F714DD50

Q37580446-4998B6B8-25F5-45B3-9BC1-F435BE38F025

Q37580446-4E8F7440-B4DB-4545-9C2C-EC4EB2A1F4E3

Q37580446-547CA356-6BEC-4FB3-AC0E-4BC5941F99B9

Q37580446-64AD5754-0B79-4989-876C-FA83D41C4E33

Q37580446-9C504D4A-89D0-4457-89EE-115DB255B6F5

P2860

Q37580446-04E465C9-39E6-478C-AF40-C1E1BBED5E00

Q37580446-05F985E6-752E-45BC-91DD-A301E775FAF5

Q37580446-1428DBA4-000E-4921-B006-035A03493AC5

Q37580446-213DAB34-4DD6-4C8D-A8D8-7063B143DBF7

Q37580446-339DED53-9BB1-4C64-A67E-93C034CACF6C

Q37580446-3B38830E-1016-4B27-B60F-6BF9C99371D6

Q37580446-5F8C6071-315D-4747-B21B-5F0CC0C26E01

Q37580446-6F97EBDD-A7CB-494E-ADE9-9A5745C39A42

Q37580446-84DDF365-451A-4F5C-BA0D-D08D1D41E19D

Q37580446-8B9B0783-F4F9-4B6B-A0E7-E2FCACC9B5E8

P304

Q37580446-72ED10D9-C350-40A8-9692-3DC0293BE9E1

P31

Q37580446-FEFA95EE-E5E8-47D9-9469-22823164D6F3

P356

Q37580446-CBBD4302-AEC0-45E2-9722-DFA7749777AE

P407

Q37580446-0B85E579-71E3-4051-BABD-ABCA765B9BF8

P433

Q37580446-E14906BA-8C2A-467F-9DA2-8748DE8097BD

P478

Q37580446-4E956F89-4322-4C1F-B29D-F25FF4DA04F4

P577

Q37580446-32F568B0-316B-4C4A-9F92-3B81ED31FBA2

P698

Q37580446-85B0EACC-A5D7-4397-94F4-A41ED417FA62

P921

Q37580446-E3C1471B-C6F0-49F1-B2F5-EAE2922A6774

P932

Q37580446-8E8B366E-9FF0-46E0-A781-8E7AAB13DB1B

P356

ONCOTARGET.10456

P1433

P1476

Efficacy of trastuzumab beyond ...... ve observational cohort study.

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Huiqin Jiang

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Ruihua Xu

http://www.w3.org/2001/XMLSchema#string

Shan Yu

http://www.w3.org/2001/XMLSchema#string

Tianshu Liu

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

Yiyi Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Cancer statistics, 2012

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2 over-expression.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.

HER2-positive gastric cancer.

Cancer epidemiology and control in North-Western and Central Asia - past, present and future.

P304

50656-50665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10456

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27409420

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

5226611

http://www.w3.org/2001/XMLSchema#string